Orphan receptors COUP-TF and DAX-1 as targets in disordered CYP17 expression in adrenocortical tumors

H Shibata1, Y Ikeda, K Morohashi

  • 1Health Center and Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan. hiro-405@cb3.so-net.ne.jp

Endocrine Research
|February 24, 2001
PubMed

Insights

The study found that the expression of orphan receptors COUP-TF and DAX-1 is inversely related to CYP17 gene expression in adrenocortical tumors. This suggests their role in excessive hormone production in these tumors.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • CYP17 gene transcription is regulated by SF-1, COUP-TF, and DAX-1 orphan receptors.
  • SF-1 activates transcription, while COUP-TF and DAX-1 inhibit it.
  • The role of these receptors in adrenocortical tumors is not fully understood.

Purpose of the Study:

  • To investigate the expression levels of SF-1, COUP-TF, and DAX-1 in adrenocortical tumors.
  • To correlate the expression of these orphan receptors with CYP17 expression.
  • To determine the pathophysiologic role of these receptors in excessive hormone production in adrenocortical tumors.

Main Methods:

  • Analysis of orphan receptor and CYP17 gene expression in cortisol-producing and deoxycorticosterone-producing adenomas.
  • Comparison of expression levels between tumor types and with normal adrenal tissue (implied).

Main Results:

  • CYP17 was highly expressed in cortisol-producing adenomas, with low COUP-TF and DAX-1.
  • CYP17 was lowly expressed in deoxycorticosterone-producing adenomas, with high DAX-1 and decreased SF-1.
  • Reciprocal expression patterns observed between CYP17 and transcriptional repressors COUP-TF and DAX-1.

Conclusions:

  • The findings suggest a pathophysiologic role for COUP-TF and DAX-1 in adrenocortical tumors.
  • Reciprocal expression of CYP17 and these repressors indicates their involvement in excessive hormone production.
  • Further research into these molecular mechanisms could lead to novel therapeutic strategies.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...